India Oncology Market 2023-2027

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $2,500	139 Pages	TechNavio	April, 2023	INF17873779

Best Price Guarantee
Price	from $2,500
Length	139 Pages
Publisher	TechNavio
Published Date	April, 2023
SKU	INF17873779

Global Oncology Market In India 2023-2027

Technavio has been monitoring the oncology market in India and is forecast to grow by USD 947.84 mn during 2022-2027, accelerating at a CAGR of 13.45% during the forecast period. Our report on the oncology market provides a holistic analysis, market size, and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the increased prevalence of cancer, the need for cost-cutting in drug discovery and development, and the increasing demand for precision medicine.

Technavio's oncology market is segmented as below:

By Type

Cancer treatment
Cancer diagnostics

By End-user

Hospitals
Diagnostic laboratories
Diagnostic imaging centers
Others

This study identifies the rise in R and D as one of the prime reasons driving the oncology market growth during the next few years. Also, the rising adoption of immunotherapy and the rising adoption of robotic surgeries will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources through an analysis of key parameters. Our report on the oncology market covers the following areas:

Oncology market sizing
Oncology market forecast
Oncology market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading oncology market vendors that include 3M Co., Abbott Laboratories, Alkem Laboratories Ltd., AstraZeneca Plc, Baxter International Inc., Bristol Myers Squibb Co., Cipla Ltd., F. Hoffmann La Roche Ltd., GE Healthcare Technologies Inc., Glenmark Pharmaceuticals Ltd., Lupin Ltd., Medtronic Plc, Merck and Co. Inc., NATCO Pharma Ltd., Novartis AG, Poly Medicure Ltd., Siemens Healthineers AG, Sun Pharmaceutical Industries Ltd., Torrent Pharmaceuticals Ltd., and Zydus Lifesciences Ltd. Also, the oncology market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources through an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

1 Executive Summary: 1.1 Market overview; Exhibit 01: Executive Summary - Chart on Market Overview; Exhibit 02: Executive Summary - Data Table on Market Overview; Exhibit 03: Executive Summary - Chart on Country Market Characteristics; Exhibit 04: Executive Summary - Chart on Market Segmentation by Type; Exhibit 05: Executive Summary - Chart on Market Segmentation by End-user; Exhibit 06: Executive Summary - Chart on Vendor Market Positioning
2 Market Landscape: 2.1 Market ecosystem; Exhibit 07: Parent market; Exhibit 08: Market Characteristics
3 Market Sizing: 3.1 Market definition; Exhibit 09: Offerings of vendors included in the market definition; 3.2 Market segment analysis; Exhibit 10: Market segments; 3.3 Market size 2022; 3.4 Market outlook: Forecast for 2022-2027; Exhibit 11: Chart on India - Market size and forecast 2022-2027 ($ million); Exhibit 12: Data Table on India - Market size and forecast 2022-2027 ($ million); Exhibit 13: Chart on India: Year-over-year growth 2022-2027 (%); Exhibit 14: Data Table on India: Year-over-year growth 2022-2027 (%)
4 Historic Market Size: 4.1 Oncology market in India 2017 - 2021; Exhibit 15: Historic Market Size - Data Table on Oncology market in India 2017 - 2021 ($ million); 4.2 Type Segment Analysis 2017 - 2021; Exhibit 16: Historic Market Size - Type Segment 2017 - 2021 ($ million); 4.3 End user Segment Analysis 2017 - 2021; Exhibit 17: Historic Market Size - End user Segment 2017 - 2021 ($ million)
5 Five Forces Analysis: 5.1 Five forces summary; Exhibit 18: Five forces analysis - Comparison between 2022 and 2027; 5.2 Bargaining power of buyers; Exhibit 19: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027; 5.3 Bargaining power of suppliers; Exhibit 20: Bargaining power of suppliers - Impact of key factors in 2022 and 2027; 5.4 Threat of new entrants; Exhibit 21: Threat of new entrants - Impact of key factors in 2022 and 2027; 5.5 Threat of substitutes; Exhibit 22: Threat of substitutes - Impact of key factors in 2022 and 2027; 5.6 Threat of rivalry; Exhibit 23: Threat of rivalry - Impact of key factors in 2022 and 2027; 5.7 Market condition; Exhibit 24: Chart on Market condition - Five forces 2022 and 2027
6 Market Segmentation by Type: 6.1 Market segments; Exhibit 25: Chart on Type - Market share 2022-2027 (%); Exhibit 26: Data Table on Type - Market share 2022-2027 (%); 6.2 Comparison by Type; Exhibit 27: Chart on Comparison by Type; Exhibit 28: Data Table on Comparison by Type; 6.3 Cancer treatment - Market size and forecast 2022-2027; Exhibit 29: Chart on Cancer treatment - Market size and forecast 2022-2027 ($ million); Exhibit 30: Data Table on Cancer treatment - Market size and forecast 2022-2027 ($ million); Exhibit 31: Chart on Cancer treatment - Year-over-year growth 2022-2027 (%); Exhibit 32: Data Table on Cancer treatment - Year-over-year growth 2022-2027 (%); 6.4 Cancer diagnostics - Market size and forecast 2022-2027; Exhibit 33: Chart on Cancer diagnostics - Market size and forecast 2022-2027 ($ million); Exhibit 34: Data Table on Cancer diagnostics - Market size and forecast 2022-2027 ($ million); Exhibit 35: Chart on Cancer diagnostics - Year-over-year growth 2022-2027 (%); Exhibit 36: Data Table on Cancer diagnostics - Year-over-year growth 2022-2027 (%); 6.5 Market opportunity by Type; Exhibit 37: Market opportunity by Type ($ million); Exhibit 38: Data Table on Market opportunity by Type ($ million)
7 Market Segmentation by End-user: 7.1 Market segments; Exhibit 39: Chart on End-user - Market share 2022-2027 (%); Exhibit 40: Data Table on End-user - Market share 2022-2027 (%); 7.2 Comparison by End-user; Exhibit 41: Chart on Comparison by End-user; Exhibit 42: Data Table on Comparison by End-user; 7.3 Hospitals - Market size and forecast 2022-2027; Exhibit 43: Chart on Hospitals - Market size and forecast 2022-2027 ($ million); Exhibit 44: Data Table on Hospitals - Market size and forecast 2022-2027 ($ million); Exhibit 45: Chart on Hospitals - Year-over-year growth 2022-2027 (%); Exhibit 46: Data Table on Hospitals - Year-over-year growth 2022-2027 (%); 7.4 Diagnostic laboratories - Market size and forecast 2022-2027; Exhibit 47: Chart on Diagnostic laboratories - Market size and forecast 2022-2027 ($ million); Exhibit 48: Data Table on Diagnostic laboratories - Market size and forecast 2022-2027 ($ million); Exhibit 49: Chart on Diagnostic laboratories - Year-over-year growth 2022-2027 (%); Exhibit 50: Data Table on Diagnostic laboratories - Year-over-year growth 2022-2027 (%); 7.5 Diagnostic imaging centers - Market size and forecast 2022-2027; Exhibit 51: Chart on Diagnostic imaging centers - Market size and forecast 2022-2027 ($ million); Exhibit 52: Data Table on Diagnostic imaging centers - Market size and forecast 2022-2027 ($ million); Exhibit 53: Chart on Diagnostic imaging centers - Year-over-year growth 2022-2027 (%); Exhibit 54: Data Table on Diagnostic imaging centers - Year-over-year growth 2022-2027 (%); 7.6 Others - Market size and forecast 2022-2027; Exhibit 55: Chart on Others - Market size and forecast 2022-2027 ($ million); Exhibit 56: Data Table on Others - Market size and forecast 2022-2027 ($ million); Exhibit 57: Chart on Others - Year-over-year growth 2022-2027 (%); Exhibit 58: Data Table on Others - Year-over-year growth 2022-2027 (%); 7.7 Market opportunity by End-user; Exhibit 59: Market opportunity by End-user ($ million); Exhibit 60: Data Table on Market opportunity by End-user ($ million)
8 Customer Landscape: 8.1 Customer landscape overview; Exhibit 61: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Drivers, Challenges, and Trends: 9.1 Market drivers; 9.2 Market challenges; 9.3 Impact of drivers and challenges; Exhibit 62: Impact of drivers and challenges in 2022 and 2027; 9.4 Market trends
10 Vendor Landscape: 10.1 Overview; 10.2 Vendor landscape; Exhibit 63: Overview on Criticality of inputs and Factors of differentiation; 10.3 Landscape disruption; Exhibit 64: Overview on factors of disruption; 10.4 Industry risks; Exhibit 65: Impact of key risks on business
11 Vendor Analysis: 11.1 Vendors covered; Exhibit 66: Vendors covered; 11.2 Market positioning of vendors; Exhibit 67: Matrix on vendor position and classification; 11.3 Abbott Laboratories; Exhibit 68: Abbott Laboratories - Overview; Exhibit 69: Abbott Laboratories - Business segments; Exhibit 70: Abbott Laboratories - Key news; Exhibit 71: Abbott Laboratories - Key offerings; Exhibit 72: Abbott Laboratories - Segment focus; 11.4 Alkem Laboratories Ltd.; Exhibit 73: Alkem Laboratories Ltd. - Overview; Exhibit 74: Alkem Laboratories Ltd. - Business segments; Exhibit 75: Alkem Laboratories Ltd. - Key news; Exhibit 76: Alkem Laboratories Ltd. - Key offerings; Exhibit 77: Alkem Laboratories Ltd. - Segment focus; 11.5 AstraZeneca Plc; Exhibit 78: AstraZeneca Plc - Overview; Exhibit 79: AstraZeneca Plc - Product / Service; Exhibit 80: AstraZeneca Plc - Key news; Exhibit 81: AstraZeneca Plc - Key offerings; 11.6 Bristol Myers Squibb Co.; Exhibit 82: Bristol Myers Squibb Co. - Overview; Exhibit 83: Bristol Myers Squibb Co. - Product / Service; Exhibit 84: Bristol Myers Squibb Co. - Key news; Exhibit 85: Bristol Myers Squibb Co. - Key offerings; 11.7 Cipla Ltd.; Exhibit 86: Cipla Ltd. - Overview; Exhibit 87: Cipla Ltd. - Business segments; Exhibit 88: Cipla Ltd. - Key news; Exhibit 89: Cipla Ltd. - Key offerings; Exhibit 90: Cipla Ltd. - Segment focus; 11.8 F. Hoffmann La Roche Ltd.; Exhibit 91: F. Hoffmann La Roche Ltd. - Overview; Exhibit 92: F. Hoffmann La Roche Ltd. - Business segments; Exhibit 93: F. Hoffmann La Roche Ltd. - Key news; Exhibit 94: F. Hoffmann La Roche Ltd. - Key offerings; Exhibit 95: F. Hoffmann La Roche Ltd. - Segment focus; 11.9 GE Healthcare Technologies Inc.; Exhibit 96: GE Healthcare Technologies Inc. - Overview; Exhibit 97: GE Healthcare Technologies Inc. - Business segments; Exhibit 98: GE Healthcare Technologies Inc. - Key offerings; Exhibit 99: GE Healthcare Technologies Inc. - Segment focus; 11.10 Glenmark Pharmaceuticals Ltd.; Exhibit 100: Glenmark Pharmaceuticals Ltd. - Overview; Exhibit 101: Glenmark Pharmaceuticals Ltd. - Product / Service; Exhibit 102: Glenmark Pharmaceuticals Ltd. - Key offerings; 11.11 Lupin Ltd.; Exhibit 103: Lupin Ltd. - Overview; Exhibit 104: Lupin Ltd. - Product / Service; Exhibit 105: Lupin Ltd. - Key news; Exhibit 106: Lupin Ltd. - Key offerings; 11.12 Medtronic Plc; Exhibit 107: Medtronic Plc - Overview; Exhibit 108: Medtronic Plc - Business segments; Exhibit 109: Medtronic Plc - Key news; Exhibit 110: Medtronic Plc - Key offerings; Exhibit 111: Medtronic Plc - Segment focus; 11.13 Merck and Co. Inc.; Exhibit 112: Merck and Co. Inc. - Overview; Exhibit 113: Merck and Co. Inc. - Business segments; Exhibit 114: Merck and Co. Inc. - Key news; Exhibit 115: Merck and Co. Inc. - Key offerings; Exhibit 116: Merck and Co. Inc. - Segment focus; 11.14 NATCO Pharma Ltd.; Exhibit 117: NATCO Pharma Ltd. - Overview; Exhibit 118: NATCO Pharma Ltd. - Business segments; Exhibit 119: NATCO Pharma Ltd. - Key offerings; Exhibit 120: NATCO Pharma Ltd. - Segment focus; 11.15 Siemens Healthineers AG; Exhibit 121: Siemens Healthineers AG - Overview; Exhibit 122: Siemens Healthineers AG - Business segments; Exhibit 123: Siemens Healthineers AG - Key news; Exhibit 124: Siemens Healthineers AG - Key offerings; Exhibit 125: Siemens Healthineers AG - Segment focus; 11.16 Sun Pharmaceutical Industries Ltd.; Exhibit 126: Sun Pharmaceutical Industries Ltd. - Overview; Exhibit 127: Sun Pharmaceutical Industries Ltd. - Product / Service; Exhibit 128: Sun Pharmaceutical Industries Ltd. - Key offerings; 11.17 Zydus Lifesciences Ltd.; Exhibit 129: Zydus Lifesciences Ltd. - Overview; Exhibit 130: Zydus Lifesciences Ltd. - Business segments; Exhibit 131: Zydus Lifesciences Ltd. - Key offerings; Exhibit 132: Zydus Lifesciences Ltd. - Segment focus
12 Appendix: 12.1 Scope of the report; 12.2 Inclusions and exclusions checklist; Exhibit 133: Inclusions checklist; Exhibit 134: Exclusions checklist; 12.3 Currency conversion rates for US$; Exhibit 135: Currency conversion rates for US$; 12.4 Research methodology; Exhibit 136: Research methodology; Exhibit 137: Validation techniques employed for market sizing; Exhibit 138: Information sources; 12.5 List of abbreviations; Exhibit 139: List of abbreviations; Exhibits:; Exhibits1: Executive Summary - Chart on Market Overview; Exhibits2: Executive Summary - Data Table on Market Overview; Exhibits3: Executive Summary - Chart on Country Market Characteristics; Exhibits4: Executive Summary - Chart on Market Segmentation by Type; Exhibits5: Executive Summary - Chart on Market Segmentation by End-user; Exhibits6: Executive Summary - Chart on Vendor Market Positioning; Exhibits7: Parent market; Exhibits8: Market Characteristics; Exhibits9: Offerings of vendors included in the market definition; Exhibits10: Market segments; Exhibits11: Chart on India - Market size and forecast 2022-2027 ($ million); Exhibits12: Data Table on India - Market size and forecast 2022-2027 ($ million); Exhibits13: Chart on India: Year-over-year growth 2022-2027 (%); Exhibits14: Data Table on India: Year-over-year growth 2022-2027 (%); Exhibits15: Historic Market Size - Data Table on Oncology market in India 2017 - 2021 ($ million); Exhibits16: Historic Market Size - Type Segment 2017 - 2021 ($ million); Exhibits17: Historic Market Size - End user Segment 2017 - 2021 ($ million); Exhibits18: Five forces analysis - Comparison between 2022 and 2027; Exhibits19: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027; Exhibits20: Bargaining power of suppliers - Impact of key factors in 2022 and 2027; Exhibits21: Threat of new entrants - Impact of key factors in 2022 and 2027; Exhibits22: Threat of substitutes - Impact of key factors in 2022 and 2027; Exhibits23: Threat of rivalry - Impact of key factors in 2022 and 2027; Exhibits24: Chart on Market condition - Five forces 2022 and 2027; Exhibits25: Chart on Type - Market share 2022-2027 (%); Exhibits26: Data Table on Type - Market share 2022-2027 (%); Exhibits27: Chart on Comparison by Type; Exhibits28: Data Table on Comparison by Type; Exhibits29: Chart on Cancer treatment - Market size and forecast 2022-2027 ($ million); Exhibits30: Data Table on Cancer treatment - Market size and forecast 2022-2027 ($ million); Exhibits31: Chart on Cancer treatment - Year-over-year growth 2022-2027 (%); Exhibits32: Data Table on Cancer treatment - Year-over-year growth 2022-2027 (%); Exhibits33: Chart on Cancer diagnostics - Market size and forecast 2022-2027 ($ million); Exhibits34: Data Table on Cancer diagnostics - Market size and forecast 2022-2027 ($ million); Exhibits35: Chart on Cancer diagnostics - Year-over-year growth 2022-2027 (%); Exhibits36: Data Table on Cancer diagnostics - Year-over-year growth 2022-2027 (%); Exhibits37: Market opportunity by Type ($ million); Exhibits38: Data Table on Market opportunity by Type ($ million); Exhibits39: Chart on End-user - Market share 2022-2027 (%); Exhibits40: Data Table on End-user - Market share 2022-2027 (%); Exhibits41: Chart on Comparison by End-user; Exhibits42: Data Table on Comparison by End-user; Exhibits43: Chart on Hospitals - Market size and forecast 2022-2027 ($ million); Exhibits44: Data Table on Hospitals - Market size and forecast 2022-2027 ($ million); Exhibits45: Chart on Hospitals - Year-over-year growth 2022-2027 (%); Exhibits46: Data Table on Hospitals - Year-over-year growth 2022-2027 (%); Exhibits47: Chart on Diagnostic laboratories - Market size and forecast 2022-2027 ($ million); Exhibits48: Data Table on Diagnostic laboratories - Market size and forecast 2022-2027 ($ million); Exhibits49: Chart on Diagnostic laboratories - Year-over-year growth 2022-2027 (%); Exhibits50: Data Table on Diagnostic laboratories - Year-over-year growth 2022-2027 (%); Exhibits51: Chart on Diagnostic imaging centers - Market size and forecast 2022-2027 ($ million); Exhibits52: Data Table on Diagnostic imaging centers - Market size and forecast 2022-2027 ($ million); Exhibits53: Chart on Diagnostic imaging centers - Year-over-year growth 2022-2027 (%); Exhibits54: Data Table on Diagnostic imaging centers - Year-over-year growth 2022-2027 (%); Exhibits55: Chart on Others - Market size and forecast 2022-2027 ($ million); Exhibits56: Data Table on Others - Market size and forecast 2022-2027 ($ million); Exhibits57: Chart on Others - Year-over-year growth 2022-2027 (%); Exhibits58: Data Table on Others - Year-over-year growth 2022-2027 (%); Exhibits59: Market opportunity by End-user ($ million); Exhibits60: Data Table on Market opportunity by End-user ($ million); Exhibits61: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; Exhibits62: Impact of drivers and challenges in 2022 and 2027; Exhibits63: Overview on Criticality of inputs and Factors of differentiation; Exhibits64: Overview on factors of disruption; Exhibits65: Impact of key risks on business; Exhibits66: Vendors covered; Exhibits67: Matrix on vendor position and classification; Exhibits68: Abbott Laboratories - Overview; Exhibits69: Abbott Laboratories - Business segments; Exhibits70: Abbott Laboratories - Key news; Exhibits71: Abbott Laboratories - Key offerings; Exhibits72: Abbott Laboratories - Segment focus; Exhibits73: Alkem Laboratories Ltd. - Overview; Exhibits74: Alkem Laboratories Ltd. - Business segments; Exhibits75: Alkem Laboratories Ltd. - Key news; Exhibits76: Alkem Laboratories Ltd. - Key offerings; Exhibits77: Alkem Laboratories Ltd. - Segment focus; Exhibits78: AstraZeneca Plc - Overview; Exhibits79: AstraZeneca Plc - Product / Service; Exhibits80: AstraZeneca Plc - Key news; Exhibits81: AstraZeneca Plc - Key offerings; Exhibits82: Bristol Myers Squibb Co. - Overview; Exhibits83: Bristol Myers Squibb Co. - Product / Service; Exhibits84: Bristol Myers Squibb Co. - Key news; Exhibits85: Bristol Myers Squibb Co. - Key offerings; Exhibits86: Cipla Ltd. - Overview; Exhibits87: Cipla Ltd. - Business segments; Exhibits88: Cipla Ltd. - Key news; Exhibits89: Cipla Ltd. - Key offerings; Exhibits90: Cipla Ltd. - Segment focus; Exhibits91: F. Hoffmann La Roche Ltd. - Overview; Exhibits92: F. Hoffmann La Roche Ltd. - Business segments; Exhibits93: F. Hoffmann La Roche Ltd. - Key news; Exhibits94: F. Hoffmann La Roche Ltd. - Key offerings; Exhibits95: F. Hoffmann La Roche Ltd. - Segment focus; Exhibits96: GE Healthcare Technologies Inc. - Overview; Exhibits97: GE Healthcare Technologies Inc. - Business segments; Exhibits98: GE Healthcare Technologies Inc. - Key offerings; Exhibits99: GE Healthcare Technologies Inc. - Segment focus; Exhibits100: Glenmark Pharmaceuticals Ltd. - Overview; Exhibits101: Glenmark Pharmaceuticals Ltd. - Product / Service; Exhibits102: Glenmark Pharmaceuticals Ltd. - Key offerings; Exhibits103: Lupin Ltd. - Overview; Exhibits104: Lupin Ltd. - Product / Service; Exhibits105: Lupin Ltd. - Key news; Exhibits106: Lupin Ltd. - Key offerings; Exhibits107: Medtronic Plc - Overview; Exhibits108: Medtronic Plc - Business segments; Exhibits109: Medtronic Plc - Key news; Exhibits110: Medtronic Plc - Key offerings; Exhibits111: Medtronic Plc - Segment focus; Exhibits112: Merck and Co. Inc. - Overview; Exhibits113: Merck and Co. Inc. - Business segments; Exhibits114: Merck and Co. Inc. - Key news; Exhibits115: Merck and Co. Inc. - Key offerings; Exhibits116: Merck and Co. Inc. - Segment focus; Exhibits117: NATCO Pharma Ltd. - Overview; Exhibits118: NATCO Pharma Ltd. - Business segments; Exhibits119: NATCO Pharma Ltd. - Key offerings; Exhibits120: NATCO Pharma Ltd. - Segment focus; Exhibits121: Siemens Healthineers AG - Overview; Exhibits122: Siemens Healthineers AG - Business segments; Exhibits123: Siemens Healthineers AG - Key news; Exhibits124: Siemens Healthineers AG - Key offerings; Exhibits125: Siemens Healthineers AG - Segment focus; Exhibits126: Sun Pharmaceutical Industries Ltd. - Overview; Exhibits127: Sun Pharmaceutical Industries Ltd. - Product / Service; Exhibits128: Sun Pharmaceutical Industries Ltd. - Key offerings; Exhibits129: Zydus Lifesciences Ltd. - Overview; Exhibits130: Zydus Lifesciences Ltd. - Business segments; Exhibits131: Zydus Lifesciences Ltd. - Key offerings; Exhibits132: Zydus Lifesciences Ltd. - Segment focus; Exhibits133: Inclusions checklist; Exhibits134: Exclusions checklist; Exhibits135: Currency conversion rates for US$; Exhibits136: Research methodology; Exhibits137: Validation techniques employed for market sizing; Exhibits138: Information sources; Exhibits139: List of abbreviations